(Q39660386)

13 September 2017

title

Sorafenib induces growth inhibition and apoptosis of human chondrosarcoma cells by blocking the RAF/ERK/MEK pathway (English)

1 reference

13 September 2017

1 reference

Xinchang Lu

1

1 reference

13 September 2017

Xiaodong Tang

2

1 reference

13 September 2017

Wei Guo

3

1 reference

13 September 2017

Tingting Ren

4

1 reference

13 September 2017

Hui Zhao

5

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20812347

5 July 2024

publication date

1 December 2010

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjso.21661

1 reference

https://api.crossref.org/works/10.1002/JSO.21661

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.21661

5 July 2024

1 reference

https://api.crossref.org/works/10.1002/JSO.21661

Journal of Surgical Oncology

5 July 2024

published in

1 reference

13 September 2017

volume

102

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

821-826

1 reference

Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report

13 September 2017

cites work

1 reference

The clinical approach towards chondrosarcoma

21 January 2018

1 reference

RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo

21 January 2018

1 reference

Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer

21 January 2018

1 reference

Glial cell-derived neurotrophic factor increases migration of human chondrosarcoma cells via ERK and NF-kappaB pathways.

21 January 2018

1 reference

CTGF enhances migration and MMP-13 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells

21 January 2018

1 reference

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.

21 January 2018

1 reference

RB and cell cycle progression

21 January 2018

1 reference

The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006.

21 January 2018

1 reference

Signal integration by JNK and p38 MAPK pathways in cancer development

21 January 2018

1 reference

Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway.

21 January 2018

1 reference

The p38 MAPK stress pathway as a tumor suppressor or more?

21 January 2018

1 reference

Sorafenib induces growth inhibition and apoptosis in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK signaling pathway.

21 January 2018

1 reference

Bcl-2 family proteins and cancer

21 January 2018

1 reference

21 January 2018

Sorafenib

https://api.crossref.org/works/10.1002/JSO.21661

9

1 reference

5 July 2024

Identifiers

DOI

10.1002/JSO.21661

1 reference

13 September 2017

1 reference